Mumbai, April 7 -- Sun Pharmaceutical Industries has launched Fexuprazan tablets 40 mg in India under the brand name "FEXUCLUE(R)". FEXUCLUE(R), a novel potassium competitive acid blocker (PCAB), is approved as a new treatment for adults with Erosive Esophagitis of all grades.

Published by HT Digital Content Services with permission from Capital Market....